Category Archives: Government/Research

Mississippi Joins States for Psychedelic Experimentation

A neon-lit chemical molecular structure floating in a colorful cosmic nebula with stars and galaxies.

Mississippi is now following Texas and a handful of other states, by positioning itself on the frontier of a potential neurological revolution. On March 19, 2026, Mississippi Governor Tate Reeves made history by signing HB 314 into law, authorizing the Mississippi State Department of Health to use $5 million of Mississippi’s opioid settlement money to fund clinical trials for the drug ibogaine. The bill takes effect July 1 and allows Mississippi to coordinate trials with other states, including Texas, which has already committed to its own program.

A psychoactive substance derived from the root of a plant native to Africa, ibogaine has been used for centuries in spiritual and healing ceremonies. More recently, it has gained scientific interest for its potential to treat opioid and cocaine addiction. Research suggests it increases signaling of important brain molecules linked to drug addiction and depression. Currently a Schedule I controlled substance, Americans seeking treatment must travel abroad at costs that reportedly reach up to $50,000 per session.

As stated by Dr. Nolan Williams, who was involved in the landmark 2024 Stanford University study that brought attention to the use of ibogaine for brain injury, “no other drug has ever been able to alleviate the functional and neuropsychiatric symptoms of traumatic brain injury.”

Brain Booster in Easter Basket & Candy Aisle Year-round

Wicker basket filled with chocolate peanut butter cups and colorful pastel candy eggs.

This Easter, as you unwrap a peanut butter egg, you may be doing your mind a bigger favor than you realize.

Peanut butter is a quiet powerhouse for cognitive health, loaded with niacin (B3) and vitamin E. Though peanuts may be in the legume family, rather than a nut, its brain benefits fall in line with them. A recent and compelling study, published in November 2025 by Clinical Nutrition, and accessible through PubMed, is a randomized crossover trial that gave 31 healthy older adults 60g/day of skin-roasted peanuts for 16 weeks. Using MRI scans as a guide, the authors concluded: “Daily consumption of skin-roasted peanuts for 16 weeks improved brain vascular function in healthy older men and women. These favorable effects may underlie the observed improvements in verbal memory.”

Dark chocolate truffle with a bite taken out revealing a creamy peanut butter center.

The implications run deeper than better recall, as studies have long proven. A 2024 review, prepared under a Defense Health Agency contract, found that, “preclinical studies and early human trials suggest that specific nutrients and diets may offer neuroprotection or benefit during mild TBI rehabilitation.” Peanut butter’s niacin is among the compounds flagged by PubMed research as exhibiting neuroprotective properties by reducing lesion volume, oxidative stress, and neuronal damage after TBI.

The brain benefits of dark chocolate have also been widely proven. So, year-round, if you’re browsing the candy aisle, try looking for dark chocolate peanut butter cups for a brain boost.  

Your Eyes Can Reveal What’s In Your Brain

In March 2026, the University of Colorado Anschutz Medical Campus published the results of a study that reveals high-speed eye-tracking technology can detect lasting neurological damage from mild traumatic brain injuries. More so, it showed that the damage that can be detected may be completely invisible to MRI scans, CT imaging, and routine clinical exams. This matters enormously. Current standard concussion assessments are largely subjective and can result in patients being told they’ve recovered when their brains are still struggling.

At the CU’s Marcus Institute for Brain Health, researchers tested 78 military veterans and measured subtle disruptions in eye movement that expose hidden neural damage. The findings were sobering: deficits persisted 10 to 15 years after the original injury. As Dr. Jeffrey Hebert, who led the study, noted, “Even when someone feels recovered, their brain may still be working differently behind the scenes.” Funded by the Department of Defense, this technology offers something conventional medicine currently cannot – objective, documented proof of brain trauma.

Man’s Best Friend Aids Brain Injury Recovery

Dogs are proving to be powerful partners in brain injury rehabilitation, offering benefits across physical, emotional, and speech therapy alike.

A March 2026 story from the University of Colorado Health (UCHealth) system documented Alan Tay, a 71-year-old stroke survivor who credits his border collie Olay with driving his recovery. Working with a neurological physical therapist, Alan used dog agility training to rebuild endurance, coordination, and memory – ultimately winning a national canine competition just three months after his stroke. Emotionally, dogs combat the depression and isolation that frequently accompany brain injury. The above-mentioned UCHealth story also notes that Olay gave Alan the will to push through. An NIH-funded clinical trial confirmed that service dogs may meaningfully reduce PTSD symptoms in military members and veterans.

Dogs can assist with speech recovery, as well. Research shows that aphasia patients produce more verbal and nonverbal communication around therapy dogs, which respond to tone and gesture rather than specific words. Speech therapy in such a uniquely low-pressure and therapeutic environment is highly beneficial for language practice.

The bipartisan SAVES Act, which reached the Senate calendar in February 2026, would fund service dogs for veterans with TBI and PTSD. Introduced by Rep. Morgan Luttrell (TX) on April 2, 2025, H.R.2605 explicitly lists “Traumatic brain injury” as a covered condition, recognizing that a trained service dog can be “optimal for the veteran to manage the disability, condition, or diagnosis and live independently.” In March 2026, America’s VetDogs launched a national campaign during this Brain Injury Awareness Month that highlights service dogs’ life-changing impact for TBI survivors, particularly as it relates to counter-balance support and deep pressure therapy.

Bacterium in Your Lungs May Be Attacking Your Brain

Chlamydia pneumoniae is a common respiratory bacterium responsible for millions of cases of pneumonia and sinus infections each year. Most people recover without incident, but a growing body of research suggests the bacterium doesn’t always leave. In a February 2026 study, published in Nature Communications, researchers at Cedars-Sinai found that Chlamydia pneumoniae can linger in the eye and brain for years, potentially aggravating Alzheimer’s disease. Scientists found that greater amounts of the bacterium were associated with more severe brain damage and worse cognitive decline, with elevated bacterial levels especially common in individuals carrying the APOE4 gene variant.

The mechanism is alarming. The bacterium can infect the olfactory and trigeminal nerves and reach the brain within 72 hours, while also dysregulating key pathways involved in Alzheimer’s disease pathogenesis.

The federal government has taken notice. The Senate Appropriations Committee’s FY 2026 spending bill proposed an increase of $100 million for Alzheimer’s disease and related dementias research at NIH National Institute on Aging. Researchers hope this increased funding hope will accelerate investigation into infection-driven neurodegeneration. What once seemed like an ordinary respiratory bug may prove to be one of the brain’s most dangerous long-term adversaries.

Cerebral Palsy: When a Damaged Brain Leaves a Lasting Mark

The brain injury comes first. Cerebral palsy follows. That distinction matters enormously, as CP is not itself a wound, but rather the permanent shadow one leaves behind.

The NIH’s National Institute of Neurological Disorders and Stroke guidance, reviewed as recently as March 13, 2026, describes CP as a disorder “caused by changes in the developing brain that disrupt its ability to control movement and maintain posture and balance.” The damage happens; CP is an outcome that the victim must live with in the future.

For most, the injury strikes before they ever draw a first breath. Oxygen deprivation during delivery, bleeding in the brain, or destruction of the delicate white matter surrounding a premature infant’s ventricles collectively account for roughly 80–90% of all cases. The CDC, in a February 2026 update, puts the scale in stark terms: about 1 in every 345 American children has CP, making it the most common childhood motor disability in the country.

Some cases, however, emerge after birth. Meningitis, near-drowning, and traumatic brain injury can all trigger CP, but only during the critical window when the brain is still forming, generally before age five. Once the skull has fully matured, the same injuries are referred to as traumatic brain injuries or acquired brain injuries.

To remedy what many see as the government’s chronic underfunding for CP, Tennessee Rep. Steve Cohen introduced H.R. 2178, Cerebral Palsy Research Program Authorization Act of 2025, on March 18, 2025. As he stated, “Cerebral palsy… is the most prevalent disability that has no designated federal funding for research.” After introduction, the bill was referred to the House Committee on Energy and Commerce. (No further action within the last Congressional session is reported.)

Cherry-Picking Superfoods to Aid TBI Recovery

A small red fruit that appears in various forms throughout the year is more than simply a tasty treat. Cherries pack natural pigment, known as anthocyanins, melatonin, and quercetin that cross the blood-brain barrier, reduce neuroinflammation, and protect injured neurons. It has long been known that anthocyanins cut brain injury volume by up to 27%, with anti-inflammatory potency similar to that of ibuprofen. Three more recent human randomized controlled trials also confirmed measurable improvements in memory, attention, and mental fatigue after daily tart cherry juice consumption.

These neurological improvements, highly beneficial to those with brain injuries, include a 23% reduction in memory errors in one 12-week. The NIH’s National Academies Press identified polyphenols found abundantly in cherries as interacting with neuronal survival pathways after traumatic brain injury (TBI). A 2025 review in Nutritional Neuroscience concluded that these compounds lessen neuroinflammation and oxidative stress following brain injury. An earlier comprehensive USDA-supported review of 29 human cherry studies also found cherry consumption decreased oxidative stress markers in 8 of 10 studies and reduced inflammation in 11 of 16 studies.

However, studies show that not all cherries deliver equal benefits. Montmorency tart cherries provide the highest benefits, though dark sweet varieties also carry high anthocyanin levels. Cherries also do not need to be eaten raw to be advantageous. Liquefied tart cherry juice concentrate has proven to be the most clinically validated form, though cherries that have been cooked retain significant amounts of active compounds. When frozen, cherries still provide these benefits, as they preserve 90–95% of polyphenols.

*Beyond delicious cherry pie, recipe research shows me that cherries are a feature in numerous recipes that are well-suited for every time of the day. For breakfast, for example, try cherry overnight oats (rolled oats, frozen cherries, ground flaxseed, and almond butter) which requires zero morning prep and provides steady brain energy. A cherry-chocolate brain smoothie is a good snack (tart cherries blended with cocoa powder, spinach, chia seeds, and almond milk) that delivers anthocyanins and omega-3s in one glass. For TBI-related sleep disruption, tart cherry turmeric bedtime tea (cherry juice simmered with ginger, turmeric, and chamomile) supports both natural melatonin production and neuroinflammation recovery simultaneously.

University of Alabama’s COMPASS for Brain Injury Care

The University of Alabama officially launched the COMPASS Brain Health Initiative (Comprehensive Post-Acute Specialty Services) on March 4, 2026, becoming the first clinic of its kind in Alabama. The program provides free, same-day interdisciplinary evaluations for individuals living with the persistent effects of traumatic brain injury.

COMPASS is entirely funded by the Alabama Department of Rehabilitation Services (ADRS), making every evaluation free of charge. The state’s involvement runs deep: planning began in October 2025, funding was secured in December 2025, and collaboration spans the Governor’s Office, the Alabama Department of Veterans Affairs, the Department of Mental Health, and the justice system. The clinic serves an estimated 102,000 Alabamians living with TBIs, with patients split roughly equally between civilians and veterans.

ADRS TBI Director April B. Turner underscored the program’s significance: “There’s nothing like this that exists. Having a clinic where our veterans or the guard or folks in long-term recovery can come into our centers, and… have specialists that we can refer them to for free…is just pivotal.”

(ADRS also announced five satellite TBI centers across the state, in Birmingham, Mobile, Decatur, Opelika, and Enterprise, extending COMPASS’s reach statewide.)

“Eat Your Vegetables” for a Healthy Brain

Vitamin K is generally known for its role in blood clotting, but scientists have long been uncovering its powerful impact on brain health. Available to view through PubMed, biochemical journal Biofactors noted as far back as 2012, “There is now convincing evidence that vitamin K has important actions in the nervous system.” A 2022 study published in Nature, also available on PubMed, found that vitamin K suppresses ferroptosis, a type of cell death driven by lipid damage and linked to brain injury. 

Vitamin K activates brain proteins Gas6 and protein S, which shield neurons from damage and support cell recovery after injury. While the vitamin is important for all people’s brain health, it is life-or-death for infants. The CDC has reported that babies who don’t receive a vitamin K shot at birth are 81 times more likely to develop Vitamin K Deficiency Bleeding [VKDB]. Between 30% and 60% of late-onset cases of VKDB involve brain hemorrhage, and one in five affected infants will die.

More recently, the public medical library published a 2025 Tufts University study, first reported in The Journal of Nutrition, that confirmed “low vitamin K intake reduced menaquinone-4 concentrations in brain tissues and impaired learning- and memory-related cognitive function.” 

Beyond neuroprotection, the NIH Office of Dietary Supplements notes that Vitamin K strengthens bones and supports healthy blood circulation. The old adage of “eat your vegetables” is apropos, as top food sources include kale, spinach, broccoli, and Brussels sprouts.    

Developing the “Dancing Molecule”

Northwestern University scientists have developed an injectable nanomaterial, dubbed “dancing molecules”, that cross the blood-brain barrier and shield brain tissue from post-stroke damage. Published January 2026 in Neurotherapeutics, the therapy uses tiny, constantly moving molecular assemblies, known as supramolecular therapeutic peptides (STPs), delivered intravenously that self-organize into nanofibers inside injured brain tissue. In mice, a single IV dose given after blood flow was restored significantly reduced inflammation, tissue death, and harmful immune response with no observed toxicity.

In July 2025, Amphix Bio, the company behind the treatment, posted on LinkedIn: “We are thrilled to announce the FDA has granted an Orphan Drug Designation to AMFX-200, our lead candidate based on the Supramolecular Therapeutic Peptide (STP) platform, for the treatment of acute spinal cord injury. This will accelerate our efforts to bring this novel neuro-regenerative therapeutic to the clinic.”*

* I cannot find any record of human trials of this stroke treatment, as of yet. Additionally, key limitations remain, as results are preclinical only, dosing must be precise to prevent blood clotting, and long-term human safety is unproven.